SEC Form 4 · accession 0002032089-26-000002
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melissa Seymour
Officer — EVP, Global Quality
Period of report
Aug 1, 2026
Accepted (ET)
Aug 3, 2026 · 4:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2026 | M | 981 | $0.00 | A | 1,506 | D | |
| Common Stock | Aug 1, 2026 | F | 439 | $1,148.84 | D | 1,067 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Aug 1, 2026 | M | 981 | D | — | — | Common Stock | 981 | 952 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
- F2The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027.